IP Library Granted Patent US 10,071,135
Granted Patent B2
US 10,071,135 · App. 14/849,313 · Granted Sep 11, 2018

Method of identifying an agent that promotes bone growth or increases bone density

Inventors: John Knopf (Carlisle, MA); Jasbir Seehra (Lexington, MA)
Assignee: ACCELERON PHARMA INC.
A61K38/179C07K14/575C07K14/71A61K38/00C07K2319/30C07K2319/32C07K2319/35C07K2319/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,071,135
App. No.
14/849,313
Granted
Sep 11, 2018
Kind
B2
Abstract

In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density.

Claims (12)

1. A method of identifying an agent that promotes bone growth or increases bone density, the method comprising: a) identifying an agent that binds to a ligand-binding domain of an ActRIIa polypeptide competitively with an activin polypeptide; and b) evaluating the effect of the agent on bone tissue.

2. The method of claim 1 , wherein the agent is selected from the group consisting of non-peptidyl organic molecules, peptides, polypeptides, peptidomimetics, sugars, hormones, and nucleic acid molecules.

3. The method of claim 1 , wherein the agent is identified by a biochemical method.

4. The method of claim 1 , wherein the agent is identified by a mechanism based assay.

5. The method of claim 1 , wherein the agent is evaluated in a cell-based assay.

6. The method of claim 1 , wherein the agent is evaluated in an in vivo assay.

7. The method of claim 1 , wherein the ActRIIa polypeptide comprises the amino acid sequence of SEQ ID NO: 2.

8. The method of claim 1 , wherein the ActRIIa polypeptide comprises the amino acid sequence of SEQ ID NO: 3.

9. The method of claim 1 , wherein the ActRIIa polypeptide comprises the amino acid sequence of SEQ ID NO: 7.

10. The method of claim 1 , wherein the ActRIIa polypeptide comprises the amino acid sequence of SEQ ID NO: 12.

11. The method of claim 1 , wherein the N-terminus of the ActRIIa polypeptide is ILGRSETQE set forth in amino acid position 1-9 of SEQ ID NO: 7.

12. The method of claim 1 , wherein the ActRIIa polypeptide consists of the amino acid sequence of SEQ ID NO: 7.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2016
From: KNOPF, JOHN; SEEHRA, JASBIR
To: ACCELERON PHARMA INC.
Reel/Frame 037831/0053 →
Continuity (8)
Continuation 14027542 · Sep 16, 2013
Continuation 13176718 · Jul 5, 2011
Continuation 12284862 · Sep 24, 2008
Continuation 11603485 · Nov 22, 2006
Provisional Application 60844855 · Sep 15, 2006
Provisional Application 60783322 · Mar 17, 2006
Provisional Application 60739462 · Nov 23, 2005
Related Publication 20160120939A1 · May 5, 2016
Cited By (1)
US 12,186,370